Rheolution News | October 2021
Rheolution announces their new partnership with the European company I&L Biosystems
Press Release
Montreal, Canada, October 5th 2021 – Rheolution announced a new partnership with Europe’s leading distributors in laboratory service and equipment I&L Biosystems. The Canadian based Life Science and Agri-food equipment company will have their ElastoSens™ Bio available in Europe with local distributors. Having already established their presence in France (with an office in Larochelle), they will now expand rapidly through Europe as I&L offers a non-compete distribution in 11 countries. Rheolution’s vision to change the viscoelasticity analytics to forge the future of life science.


“We are very excited to join forces with I&L Biosystems in our mission to empower users around the world with our cutting-edge analytical instruments to capture the dynamic evolution of live and evolving soft materials. I&L Biosystems, with its long and deep presence in key European countries, is the perfect partner to support and accelerate the execution of our strategic growth plan. Together with I&L Biosystems specialists, we will be in a better position to help our industrial and academic customers to create tomorrow’s medicine”
Anis Hadj Henni, PhD, CEO of Rheolution
I&L Biosystems delivers professional services and sales of high-quality equipment in the fields of microbiology, cell biology, biotechnology and process control. The German based company is directly present in 11 countries across Europe and employs around 90 Ph.D. scientists and highly specialized professionals supporting MedTechs, Pharma and Medical Device companies as well as top European universities and research institutes.
"Our complementary fields of services and technologies in 3D Biology make this new partnership with Rheolution a natural fit for us. We are excited to enrich our market-leading products and services portfolio with Rheolution’s technology and together join forces to answer our customers' increasing demand in innovations to shape the future of tissue engineering and 3D biology.
Alexander Beljaar, CEO of I&L Biosystems

I&L Biosystems has offered for 30 years to its 4,500 customers among laboratories, universities and listed pharmaceutical companies a variety of personalized services and a diverse portfolio of unique and carefully selected innovations and products. The partnership between Rheolution and I&L Biosystems is paving the way to the emerging fields of 3D Biology and Soft Matter Analytics for the biggest benefit of customers in Life Sciences.
Visit www.rheolution.com for more information. For inquiries, please contact :
Cyril van Robais
VP Europe
+33 6 58 24 70 07
cyril.vanrobais@rheolution.com
About Rheolution : Founded in 2009 by Cedric Schmitt and Anis Hadj Henni, Rheolution shapes the future of Soft Matter Analytics™ by delivering next-gen solutions to help it’s users bring soft materials to life. Rheolution’s mission is to empower users in their quest for innovation, quality and efficiency with it’s unique Soft Matter Analytics™ platform. The company’s cutting-edge analytical instruments reproduce real-life environments and capture the dynamic evolution of live and evolving soft materials. Rheolution designs simple-to-use, highly effective and modular analytical instruments to provide a unique testing experience for its customers in Life Sciences.
About I&L Biosystems: Founded in 1991, I&L Biosystems is a leading Europe-wide Distributor for innovative scientific products and has been growing steadily ever since. I&L Biosystems’ focus is on sales and distribution of cutting edge, high quality laboratory equipment to customers and researchers in the microbiology, cell biology and biotechnology markets in most European countries. At present, I&L Biosystems employs more than 80 employees, who take care of our existing customer base in Europe, which is steadily growing in all markets.